Efficacy of tranexamic acid in a patient with hereditary hemorrhagic telangiectasia and massive epistaxis [2];Eficacia del ácido tranexámico en un paciente con telangiectasia hemorrágica hereditaria y epistaxis masiva

Medicina Clinica

Volumn 123, Issue 3, 2004, Pages 118-119

  Pérez Del Molino, Alfonso ^a   Zarrabeitia, Roberto ^a   Fernández, África ^a   Botella, Luisa María ^a  

^a HOSPITAL SIERRALLANA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TRANEXAMIC ACID;

AGED; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE COURSE; DRUG EFFICACY; EPISTAXIS; HUMAN; LETTER; MALE; MEDICAL LITERATURE; PHYSICAL EXAMINATION; RENDU OSLER WEBER DISEASE; SPAIN; TREATMENT OUTCOME;

EID: 3142713742     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13063475     Document Type: Letter

References (8)

1. Guttmacher AE, Marchuk DA, White RI Jr. Hereditary hemorrhagic telangiectasia. N Engl J Med 1995;333:918-24.
2. st century. Postgrad Med J 2003;79:18-24.
3. Saba HI, Morelli GA, Logrono LA. Treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid. N Engl J Med 1994;330: 1789-90.
4. Sabbá C, Gallitelli M, Pascaliano G. Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia. N Engl J Med 2001;345:926.
5. Kwaan HC, Silverman S. Fibrinolytic activity in lesions of hereditary hemorrhagic telangiectasia. Arch Dermatol 1973;107:571-3.
6. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, et al. Diagnostic criteria for hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000;91:66-7.
7. Korzenik JR, Topazian MD, White R. Treatment of bleeding in hereditary hemorrhagic telangiectasia whit aminocaproic acid. N Engl J Med 1994; 331:1236.
8. Klepfish A, Berrebi A, Schattner A. Intranasal tranexamic acid treatment for severe epistaxis in hereditary hemorrhagic telangiectasia. Arch Intern Med 2001;161:767.